iMARS focuses on image manipulation and morphing attacks on ID documents, while PharmaLedger addresses counterfeit medicines — both directly aligned with INCM's core anti-counterfeiting mission.
IMPRENSA NACIONAL - CASA DA MOEDA, S. A.
Portugal's national mint and security printer, contributing anti-counterfeiting, document fraud detection, and blockchain authentication expertise to EU research.
Their core work
INCM is Portugal's national mint and official security printing house, responsible for producing banknotes, coins, passports, identity documents, and other high-security printed materials. In H2020, they contribute deep expertise in document security, anti-counterfeiting technologies, and secure identity verification — areas directly tied to their core mission. Their R&D participation spans blockchain-based supply chain authentication, biometric document fraud detection, and cybersecurity for critical infrastructure, reflecting a traditional security printer evolving into a digital trust and authentication authority.
What they specialise in
PharmaLedger applies blockchain frameworks to pharmaceutical supply chains, clinical trials, and health data marketplaces.
SPHINX developed AI-driven vulnerability assessment, honeypots, and homomorphic encryption tools for healthcare infrastructure protection.
APRIL explores federated robots and manipulation of flexible materials in manufacturing, potentially linked to INCM's own production modernization needs.
How they've shifted over time
INCM entered H2020 in 2019-2020 with a strong focus on digital security infrastructure — blockchain for pharmaceuticals, AI-powered cybersecurity for health systems, and secure data handling with homomorphic encryption. Their more recent projects shifted toward physical-digital convergence: detecting morphing attacks on ID documents (iMARS) and robotic manufacturing of flexible materials (APRIL). This trajectory suggests a security printing house systematically building R&D capacity across both digital trust technologies and next-generation secure production processes.
INCM is moving toward AI-powered document authentication and biometric fraud prevention, positioning itself as a digital identity and trust authority beyond traditional printing.
How they like to work
INCM participates exclusively as a partner, never coordinating — consistent with a domain-specialist organization that contributes specific security and authentication expertise to larger consortia. With 81 unique partners across 23 countries from just 4 projects, they operate in large, diverse European consortia (averaging ~20 partners per project). This suggests they are a trusted specialist contributor that research coordinators seek out for their unique real-world authority in document security and anti-counterfeiting.
Despite only 4 projects, INCM has built connections with 81 partners across 23 countries, indicating participation in large pan-European consortia. Their network spans security, health, and manufacturing sectors with broad geographic coverage across the EU.
What sets them apart
INCM brings something almost no other H2020 partner can: operational authority over national identity documents, currency, and security printing. This means they don't just research anti-counterfeiting — they are the institution that must implement it at scale. For consortium builders, partnering with INCM provides direct access to a real-world deployment environment for document security, biometric verification, and trust infrastructure technologies, plus the credibility of a centuries-old national institution.
Highlights from their portfolio
- iMARSDirectly aligned with INCM's core mission — detecting image manipulation and morphing attacks on identity documents, making INCM a uniquely credible partner in this consortium.
- PharmaLedgerMajor blockchain initiative for pharmaceutical anti-counterfeiting with INCM's largest funding (EUR 365,625), extending their counterfeiting expertise from documents to medicines.
- APRILAn unusual pivot into robotics and flexible material manufacturing, suggesting INCM is modernizing its own production capabilities through EU research collaboration.